Skip to main content
Top
Published in: Medical Microbiology and Immunology 2-3/2004

01-05-2004 | Original Investigation

The humoral immune response in viral heart disease: characterization and pathophysiological significance of antibodies

Authors: Peter L. Schwimmbeck, Boris Bigalke, Karsten Schulze, Matthias Pauschinger, Uwe Kühl, Heinz-Peter Schultheiss

Published in: Medical Microbiology and Immunology | Issue 2-3/2004

Login to get access

Abstract

Several lines of evidence suggest a viral infection as the initiating event for the development of myocarditis (MC). Especially enteroviruses like coxsackie B3 virus have been shown to induce MC in humans and strains of MC-prone mice after an infection. The further course of the disease is, however, determined not only by the viral infection but also by the host’s immune system. Both the humoral and the cellular immune system can modify the extent of the damage caused by the disease. The humoral immune system mounts an anti-viral immune response immediately after the infection; however, during the course of the disease, autoantibodies against a variety of different autoantigens emerge. The epitopes recognized by the anti-viral antibodies and those of several autoantibodies have been identified using synthetic peptides. The human disease could be transferred into SCID mice using peripheral blood leukocytes of patients, suggesting a pathophysiological significance of the autoimmune reaction. However, the significance of the humoral immune responses needs to be tested in randomized, prospective studies using immunoadsorption of autoantibodies in patients with inflammatory cardiomyopathy.
Literature
1.
go back to reference Bosma GC, Custer RP, Bosma MJ (1983) A severe combined immunodeficiency mutation in the mouse. Nature 301:527–530PubMed Bosma GC, Custer RP, Bosma MJ (1983) A severe combined immunodeficiency mutation in the mouse. Nature 301:527–530PubMed
2.
go back to reference Bowles NE, Richardson PJ, Olsen EGJ, Archard LC (1986) Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet I:1120–1123CrossRef Bowles NE, Richardson PJ, Olsen EGJ, Archard LC (1986) Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet I:1120–1123CrossRef
3.
go back to reference De Scheerder IK, De Buyzere M, Delanghe J, Maas A, Clement DL, Wieme R (1991) Humoral immune response against contractile proteins (actin and myosin) during cardiovascular disease. Eur Heart J 12 (Suppl D):88–94 De Scheerder IK, De Buyzere M, Delanghe J, Maas A, Clement DL, Wieme R (1991) Humoral immune response against contractile proteins (actin and myosin) during cardiovascular disease. Eur Heart J 12 (Suppl D):88–94
4.
go back to reference Duchusal MA, McConahey PJ, Robinson CA, Dixon FJ (1990) Transfer of human lupus erythmatodes in severe combined immunodeficient (SCID) mice. J Exp Med 172:985–988PubMed Duchusal MA, McConahey PJ, Robinson CA, Dixon FJ (1990) Transfer of human lupus erythmatodes in severe combined immunodeficient (SCID) mice. J Exp Med 172:985–988PubMed
5.
go back to reference Felix SB, Staudt A, Doerffel WV (2000) Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study. J Am Coll Cardiol 35:1590–1598CrossRefPubMed Felix SB, Staudt A, Doerffel WV (2000) Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study. J Am Coll Cardiol 35:1590–1598CrossRefPubMed
6.
go back to reference Gnann JW, Schwimmbeck PL, Nelson JA, Truax BB, Oldstone MBA (1987) Diagnosis of AIDS using a 12 amino acid peptide representing an immunodominant epitope of human immunodeficiency virus. J Infect Dis 156:261–267 Gnann JW, Schwimmbeck PL, Nelson JA, Truax BB, Oldstone MBA (1987) Diagnosis of AIDS using a 12 amino acid peptide representing an immunodominant epitope of human immunodeficiency virus. J Infect Dis 156:261–267
7.
go back to reference Haarmann CM, Schwimmbeck PL, Mertens T, Schultheiss HP, Strauer B (1994) Identification of serotype-specific and nonserotype-specific B-cell epitopes of Coxsackie B viruses using synthetic peptides. Virology 200:381–389CrossRefPubMed Haarmann CM, Schwimmbeck PL, Mertens T, Schultheiss HP, Strauer B (1994) Identification of serotype-specific and nonserotype-specific B-cell epitopes of Coxsackie B viruses using synthetic peptides. Virology 200:381–389CrossRefPubMed
8.
go back to reference Helin M, Savola J, Lapinleimu K (1968) Cardiac manifestations during a coxsackie B5 epidemic. Br Med J 3:97–99PubMed Helin M, Savola J, Lapinleimu K (1968) Cardiac manifestations during a coxsackie B5 epidemic. Br Med J 3:97–99PubMed
9.
go back to reference Huber SA, Lodge PA (1984) Coxsackie B3 myocarditis in BALB/c mice: evidence for autoimmunity to myocyte antigens. Am J Physiol 116:21–27 Huber SA, Lodge PA (1984) Coxsackie B3 myocarditis in BALB/c mice: evidence for autoimmunity to myocyte antigens. Am J Physiol 116:21–27
10.
go back to reference Huber SA, Polgar J, Moraska A, Cunningham M, Schwimmbeck P, Schultheiss HP (1993) T lymphocyte responses in CVB3-induced murine myocarditis. Scand J Infect Dis 88:67–78 Huber SA, Polgar J, Moraska A, Cunningham M, Schwimmbeck P, Schultheiss HP (1993) T lymphocyte responses in CVB3-induced murine myocarditis. Scand J Infect Dis 88:67–78
11.
go back to reference Krams SM, Dorshkind K, Gershwin ME (1989) Generation of biliary lesions after transfer of human lymphocytes into severe combined immunodeficient (SCID) mice. J Exp Med 170:1919–1930PubMed Krams SM, Dorshkind K, Gershwin ME (1989) Generation of biliary lesions after transfer of human lymphocytes into severe combined immunodeficient (SCID) mice. J Exp Med 170:1919–1930PubMed
12.
go back to reference Kuehl U, Daun B, Seeberg B, Schultheiss HP, Strauer BE (1992) Dilated cardiomyopathy—a chronic myocarditis? Herz 17:97–106PubMed Kuehl U, Daun B, Seeberg B, Schultheiss HP, Strauer BE (1992) Dilated cardiomyopathy—a chronic myocarditis? Herz 17:97–106PubMed
13.
go back to reference Limas CJ, Limas C (1991) Beta-adrenoreceptor antibodies and genetics in dilated cardiomyopathy: an overview and review. Eur Heart J 12 (Suppl D):175–177 Limas CJ, Limas C (1991) Beta-adrenoreceptor antibodies and genetics in dilated cardiomyopathy: an overview and review. Eur Heart J 12 (Suppl D):175–177
14.
go back to reference Macht L, Kukuma N, Leader K, Sarsero D, Pegg CAS, Phillips DIW, Yates P, McLachlan SM, Elson C, Smith BR (1991) Severe combined immunodeficient (SCID) mice: a model for investigating human thyroid autoantibody synthesis. Clin Exp Immunol 84:34–42PubMed Macht L, Kukuma N, Leader K, Sarsero D, Pegg CAS, Phillips DIW, Yates P, McLachlan SM, Elson C, Smith BR (1991) Severe combined immunodeficient (SCID) mice: a model for investigating human thyroid autoantibody synthesis. Clin Exp Immunol 84:34–42PubMed
15.
go back to reference Mertens T, Pika U, Eggers HJ (1983) Cross antigenicity among enteroviruses as revealed by immunoblot technique. Virology 129:431–442PubMed Mertens T, Pika U, Eggers HJ (1983) Cross antigenicity among enteroviruses as revealed by immunoblot technique. Virology 129:431–442PubMed
16.
go back to reference Mueller J, Wallukat G, Dandel M (2000) Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation 35: 385–391 Mueller J, Wallukat G, Dandel M (2000) Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation 35: 385–391
17.
go back to reference Murphy WJ, Bennett M, Anver MR, Baseler M, Longo DL (1992) Human-mouse lymphoid chimeras: host-vs.-graft and graft-vs.-host reactions. Eur J Immunol 22:1421–1427PubMed Murphy WJ, Bennett M, Anver MR, Baseler M, Longo DL (1992) Human-mouse lymphoid chimeras: host-vs.-graft and graft-vs.-host reactions. Eur J Immunol 22:1421–1427PubMed
18.
go back to reference Noutsias M, Seeberg B, Schultheiss HP, Kuhl U (1999) Expression of cell adhesion molecules in dilated cardiomyopathy: evidence for endothelial activation in inflammarory cardiomyopathy. Circulation 99:2124–2131PubMed Noutsias M, Seeberg B, Schultheiss HP, Kuhl U (1999) Expression of cell adhesion molecules in dilated cardiomyopathy: evidence for endothelial activation in inflammarory cardiomyopathy. Circulation 99:2124–2131PubMed
19.
go back to reference Oldstone MBA, Schwimmbeck P, Dyrberg T, Fujinami R (1986) Mimicry by virus of host molecules: implications for autoimmune disease. In: Cinader B, Miller RG (eds) Progress in immunology, vol 4. Academic Press, San Diego, pp 787–795 Oldstone MBA, Schwimmbeck P, Dyrberg T, Fujinami R (1986) Mimicry by virus of host molecules: implications for autoimmune disease. In: Cinader B, Miller RG (eds) Progress in immunology, vol 4. Academic Press, San Diego, pp 787–795
20.
go back to reference Pauschinger M, Doerner A, Kuehl U, Schwimmbeck PL, Poller W, Kandolf R, Schulltheiss HP (1999) Enteroviral RNA replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis. Circulation 99:889–895PubMed Pauschinger M, Doerner A, Kuehl U, Schwimmbeck PL, Poller W, Kandolf R, Schulltheiss HP (1999) Enteroviral RNA replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis. Circulation 99:889–895PubMed
21.
go back to reference Phillips RA, Spaner DE (1991) The SCID mouse: mutation in a DNA repair gene creates recipients useful for studies on stem cells, lymphocyte development and graft-versus-host disease. Immunol Rev 124:63–73PubMed Phillips RA, Spaner DE (1991) The SCID mouse: mutation in a DNA repair gene creates recipients useful for studies on stem cells, lymphocyte development and graft-versus-host disease. Immunol Rev 124:63–73PubMed
22.
go back to reference Richardson P, McKenna W, Bristow M (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 93:841–842PubMed Richardson P, McKenna W, Bristow M (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 93:841–842PubMed
23.
go back to reference Rowe M, Young LS, Crocker J, Stokes H, Henderson S, Rickinson AB (1991) Epstein-Barr virus (EBV) -associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man. J Exp Med 173:147–158PubMed Rowe M, Young LS, Crocker J, Stokes H, Henderson S, Rickinson AB (1991) Epstein-Barr virus (EBV) -associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man. J Exp Med 173:147–158PubMed
24.
go back to reference Rubin LA, Nelson DL (1990) The soluble interleukin-2 receptor: Biology, function and clinical application. Ann Intern Med 113:619–627PubMed Rubin LA, Nelson DL (1990) The soluble interleukin-2 receptor: Biology, function and clinical application. Ann Intern Med 113:619–627PubMed
25.
go back to reference Schultheiss HP, Bolte HD, Schwimmbeck P, Klingenberg M (1983) The antigenic characteristics and the significance of the adenine nucleotide translocator (ANT) as a major autoantigen for antimitochondrial antibodies in myocarditis and congestive cardiomyopathy. J Mol Cell Cardiol 15:85–93 Schultheiss HP, Bolte HD, Schwimmbeck P, Klingenberg M (1983) The antigenic characteristics and the significance of the adenine nucleotide translocator (ANT) as a major autoantigen for antimitochondrial antibodies in myocarditis and congestive cardiomyopathy. J Mol Cell Cardiol 15:85–93
26.
go back to reference Schulze K, Becker BF, Schultheiss HP (1989) Antibodies to the ADP-ATP carrier—an autoantigen in myocarditis and dilated cardiomyopathy—penetrate into myocardial cells and disturb energy metabolism in vivo. Circ Res 64:179–192PubMed Schulze K, Becker BF, Schultheiss HP (1989) Antibodies to the ADP-ATP carrier—an autoantigen in myocarditis and dilated cardiomyopathy—penetrate into myocardial cells and disturb energy metabolism in vivo. Circ Res 64:179–192PubMed
27.
go back to reference Schulze K, Becker BF, Schauer R, Schultheiss HP (1990) Antibodies to ADP-ATP carrier—an autoantigen in myocarditis and dilated cardiomyopathy—impair cardiac function. Circulation 81:959–969PubMed Schulze K, Becker BF, Schauer R, Schultheiss HP (1990) Antibodies to ADP-ATP carrier—an autoantigen in myocarditis and dilated cardiomyopathy—impair cardiac function. Circulation 81:959–969PubMed
28.
go back to reference Schwimmbeck PL, Schwimmbeck NK, Schultheiss HP, Strauer BE (1993) Mapping of antigenic determinants of the adenine nucleotide translocator and coxsackie B 3 virus with synthetic peptides: use for the diagnosis of viral heart disease. Clin Immunol Immunpathol 68:135–140CrossRef Schwimmbeck PL, Schwimmbeck NK, Schultheiss HP, Strauer BE (1993) Mapping of antigenic determinants of the adenine nucleotide translocator and coxsackie B 3 virus with synthetic peptides: use for the diagnosis of viral heart disease. Clin Immunol Immunpathol 68:135–140CrossRef
29.
go back to reference Schwimmbeck PL, Badorff C, Schultheiss HP, Strauer BE (1994) Transfer of human myocarditis into severe combined immundeficiency mice. Circ Res 75:156–164PubMed Schwimmbeck PL, Badorff C, Schultheiss HP, Strauer BE (1994) Transfer of human myocarditis into severe combined immundeficiency mice. Circ Res 75:156–164PubMed
30.
go back to reference Schwimmbeck PL, Badorff C, Rohn G, Schulze K, Schultheiss HP (1996) The role of sensitized T-cells in myocarditis and dilated cardiomyopathy. Int J Cardiol 54:117–125CrossRefPubMed Schwimmbeck PL, Badorff C, Rohn G, Schulze K, Schultheiss HP (1996) The role of sensitized T-cells in myocarditis and dilated cardiomyopathy. Int J Cardiol 54:117–125CrossRefPubMed
31.
go back to reference Smith SC, Allen PM (1991) Myosin-induced acute myocarditis is a T cell-mediated disease. J Immunol 147:2141–2147PubMed Smith SC, Allen PM (1991) Myosin-induced acute myocarditis is a T cell-mediated disease. J Immunol 147:2141–2147PubMed
32.
go back to reference Tighe H, Silverman GJ, Kozin F, Tucker R, Gulizia R, Peebles C, Lotz M, Rhodes G, Machold K, Mosier DE, Carson DA (1990) Autoantibody production by severe combined immunodeficient mice reconstituted with synovial cells from rheumatoid arthritis patients. Eur J Immunol 20:1843–1848PubMed Tighe H, Silverman GJ, Kozin F, Tucker R, Gulizia R, Peebles C, Lotz M, Rhodes G, Machold K, Mosier DE, Carson DA (1990) Autoantibody production by severe combined immunodeficient mice reconstituted with synovial cells from rheumatoid arthritis patients. Eur J Immunol 20:1843–1848PubMed
33.
go back to reference Wolfgram LJ, Beisel KW, Herskowitz A, Rose NR (1986) Variations in the susceptibility to coxsackie B3 virus induced myocarditis among different strains of mice. J Immunol 136:1846–1852PubMed Wolfgram LJ, Beisel KW, Herskowitz A, Rose NR (1986) Variations in the susceptibility to coxsackie B3 virus induced myocarditis among different strains of mice. J Immunol 136:1846–1852PubMed
Metadata
Title
The humoral immune response in viral heart disease: characterization and pathophysiological significance of antibodies
Authors
Peter L. Schwimmbeck
Boris Bigalke
Karsten Schulze
Matthias Pauschinger
Uwe Kühl
Heinz-Peter Schultheiss
Publication date
01-05-2004
Publisher
Springer-Verlag
Published in
Medical Microbiology and Immunology / Issue 2-3/2004
Print ISSN: 0300-8584
Electronic ISSN: 1432-1831
DOI
https://doi.org/10.1007/s00430-003-0217-7

Other articles of this Issue 2-3/2004

Medical Microbiology and Immunology 2-3/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine